SCHEMBL20816845

SCHEMBL20816845

CC(NC(=O)C(Cc1ccccc1)NC(=O)Cc1ccccc1)C(=O)C(=O)NC(Cc1cccc(F)c1)C(=O)NC(Cc1ccc(-c2ccccc2)cc1)C(N)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 4/20 0.54
▸ SRC P12931 1/20 0.48
▸ FCER2 P06734 4/20 0.47
▸ MMP3 P08254 1/20 0.47
▸ MMP9 P14780 1/20 0.47
▸ PTPN2 P17706 2/20 0.47
▸ PTPRA P18433 1/20 0.46
▸ PTPN6 P29350 1/20 0.46
▸ PTPN11 Q06124 1/20 0.46
▸ CTSS P25774 2/20 0.45
▸ CTSL P07711 3/20 0.44
▸ GPR34 Q9UPC5 1/20 0.44
▸ CTSB P07858 1/20 0.44
▸ CNR2 P34972 1/20 0.43
▸ HPGDS O60760 2/20 0.43
▸ REN P00797 1/20 0.42
▸ MMP1 P03956 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20816880 1.00 PTPN1 (0.54) PTPN1SRCFCER2MMP3MMP9
SCHEMBL20816877 0.94 PTPN1 (0.56) PTPN1FCER2MMP3MMP9PTPN2
SCHEMBL20816696 0.94 PTPN1 (0.56) PTPN1FCER2MMP3MMP9PTPN2
SCHEMBL20816664 0.93 PTPN1 (0.58) PTPN1FCER2PTPN2PTPRAPTPN6
SCHEMBL20816879 0.93 PTPN1 (0.58) PTPN1FCER2PTPN2PTPRAPTPN6
SCHEMBL20816899 0.93 PTPN1 (0.58) PTPN1FCER2PTPN2PTPRAPTPN6
SCHEMBL20816662 0.93 PTPN1 (0.58) PTPN1FCER2PTPN2PTPRAPTPN6
SCHEMBL20816796 0.89 PTPN1 (0.58) PTPN1PTPN2PTPRAPTPN6PTPN11
SCHEMBL20827855 0.89 PTPN1 (0.60) PTPN1FCER2MMP9PTPN2PTPRA
SCHEMBL20816762 0.89 PTPN1 (0.53) PTPN1FCER2MMP3MMP9PTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190085024-A1 Alpha-Ketoamide Inhibitors Of Cysteine Proteases Phelix Therapeutics (US) 2019-03-21 — — US claimed
US-20190085024-A1 Alpha-Ketoamide Inhibitors Of Cysteine Proteases Phelix Therapeutics (US) 2019-03-21 — — US disclosed
US-20190085024-A1 Alpha-Ketoamide Inhibitors Of Cysteine Proteases Phelix Therapeutics (US) 2019-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190085024-A1 Alpha-Ketoamide Inhibitors Of Cysteine Proteases CTSS, CTSB, CTSL PTPN1 4631/4885SRC 1842/4885FCER2 4241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback